For docetaxel / Carboplatin- kombinationen kunne der hverken bevises ekvivalent eller non- inferior effekt sammenlignet med referencebehandlingen kombination VCis.
For docetaxel/ carboplatin combination, neither equivalent nor non-inferior efficacy could be proven compared to the reference treatment combination VCis.